News & Analysis on Clinical Trial Services & Contract Research And Development
By Natalie Morrison
- Last updated on
Eykerman, who is currently a partner at McKinsey & Company Brussels, will take on the role of executive VP corporate strategy and acquisitions.
A spokesperson for the company said: “With his track record of strategy development and M & A strategy and integration, Philip is well positioned to lead DSM's corporate strategy and acquisition department and drive the development of DSM's strategic growth agenda.”